Market Intelligence Resource | November 19, 2020

End-Stage Renal Disease In The Medicare Population: Frequency & Duration Of Hemodialysis & Quality Of Life Assessment, Technology Assessment

On July 14, 2020, the U.S. Department of Health & Human Services' (HHS) Agency for Healthcare Research and Quality (AHRQ) published this report on end-stage renal disease in the Medicare population. The report reports on covers the frequency and duration of hemodialysis use, and assesses the quality of life during and after hemodialysis . . .

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

About

Contact

End-Stage Renal Disease In The Medicare Population: Frequency & Duration Of Hemodialysis & Quality Of Life Assessment, Technology Assessment

Tagged As:

About

Contact

Markets

Services

Customers

Publications

Markets

Topics

Executive Institutes

Professional Development Programs

Tools

Assessments

Tagged As: